Charles Schwab
VCYT icon

Charles Schwab’s Veracyte VCYT Stock Holding History

Charles Schwab’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.2M Buy
939,983
+16,410
+2% +$688K 0.01% 1179
2026
Q1 		$29.7M Buy
923,573
+12,744
+1% +$472K ﹤0.01% 1500
2025
Q4 		$38.3M Buy
910,829
+3,058
+0.3% +$123K 0.01% 1328
2025
Q3 		$31.2M Buy
907,771
+126,831
+16% +$3.64M 0.01% 1459
2025
Q2 		$21.1M Buy
780,940
+40,309
+5% +$1.17M ﹤0.01% 1643
2025
Q1 		$22M Buy
740,631
+19,662
+3% +$749K ﹤0.01% 1592
2024
Q4 		$28.6M Sell
720,969
-14,038
-2% -$532K 0.01% 1490
2024
Q3 		$25M Sell
735,007
-27,090
-4% -$762K ﹤0.01% 1570
2024
Q2 		$16.5M Buy
762,097
+29,322
+4% +$616K ﹤0.01% 1788
2024
Q1 		$16.2M Buy
732,775
+34,357
+5% +$838K ﹤0.01% 1727
2023
Q4 		$19.2M Buy
698,418
+14,066
+2% +$340K ﹤0.01% 1626
2023
Q3 		$15.3M Sell
684,352
-3,207
-0.5% -$82.5K ﹤0.01% 1670
2023
Q2 		$17.5M Buy
687,559
+35,206
+5% +$853K 0.01% 1586
2023
Q1 		$14.5M Buy
652,353
+117
+0% +$2.83K ﹤0.01% 1682
2022
Q4 		$15.5M Buy
652,236
+11,728
+2% +$273K 0.01% 1602
2022
Q3 		$10.6M Buy
640,508
+100,995
+19% +$2.27M ﹤0.01% 1797
2022
Q2 		$10.7M Buy
539,513
+31,447
+6% +$635K ﹤0.01% 1805
2022
Q1 		$14M Buy
508,066
+2,354
+0.5% +$67.3K ﹤0.01% 1765
2021
Q4 		$20.8M Buy
505,712
+12,182
+2% +$538K 0.01% 1545
2021
Q3 		$22.9M Buy
493,530
+20,484
+4% +$894K 0.01% 1470
2021
Q2 		$18.9M Buy
473,046
+659
+0.1% +$28.2K 0.01% 1628
2021
Q1 		$25.4M Buy
472,387
+73,284
+18% +$4.22M 0.01% 1334
2020
Q4 		$19.5M Buy
399,103
+10,261
+3% +$476K 0.01% 1424
2020
Q3 		$12.6M Buy
388,842
+57,666
+17% +$1.83M 0.01% 1526
2020
Q2 		$8.58M Sell
331,176
-30,990
-9% -$772K ﹤0.01% 1740
2020
Q1 		$8.8M Sell
362,166
-37,096
-9% -$934K 0.01% 1518
2019
Q4 		$11.1M Sell
399,262
-9,758
-2% -$253K 0.01% 1612
2019
Q3 		$9.82M Buy
409,020
+187,257
+84% +$4.98M 0.01% 1615
2019
Q2 		$6.32M Buy
221,763
+55,652
+34% +$1.39M ﹤0.01% 1857
2019
Q1 		$4.16M Buy
166,111
+51,762
+45% +$988K ﹤0.01% 2059
2018
Q4 		$1.44M Buy
114,349
+5,472
+5% +$64.7K ﹤0.01% 2426
2018
Q3 		$1.04M Sell
108,877
-33,406
-23% -$368K ﹤0.01% 2613
2018
Q2 		$1.33M Sell
142,283
-24,593
-15% -$173K ﹤0.01% 2501
2018
Q1 		$928K Hold
166,876
– – ﹤0.01% 2540
2017
Q4 		$1.09M Buy
166,876
+4,314
+3% +$32.1K ﹤0.01% 2484
2017
Q3 		$1.43M Buy
162,562
+117,162
+258% +$953K ﹤0.01% 2410
2017
Q2 		$379K Buy
45,400
+22,200
+96% +$181K ﹤0.01% 2778
2017
Q1 		$213K Hold
23,200
– – ﹤0.01% 2919
2016
Q4 		$180K Hold
23,200
– – ﹤0.01% 2982
2016
Q3 		$177K Hold
23,200
– – ﹤0.01% 2939
2016
Q2 		$117K Hold
23,200
– – ﹤0.01% 3041
2016
Q1 		$126K Hold
23,200
– – ﹤0.01% 2965
2015
Q4 		$168K Hold
23,200
– – ﹤0.01% 2994
2015
Q3 		$109K Buy
23,200
+7,700
+50% +$73.3K ﹤0.01% 3027
2015
Q2 		$173K Buy
+15,500
New +$153K ﹤0.01% 3002

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Charles Schwab's VCYT Position: Q2 2026 in Review

Charles Schwab increased its Veracyte (VCYT) stake by 1.8% in Q2 2026, buying an estimated $688K and bringing the position to 939,983 shares worth $55.2M. The position accounts for 0.01% of the portfolio, ranked #1179.

Charles Schwab first reported a position in VCYT in Q2 2015 and has held it in 45 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Charles Schwab held 939,983 shares of Veracyte worth $55.2M as of Q2 2026.
  • Charles Schwab bought 16,410 Veracyte shares in Q2 2026, an estimated $688K.
  • Veracyte made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #1179 holding.
  • Charles Schwab first reported a position in Veracyte in Q2 2015 and has held it in 45 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.